JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3776
TriplePoint Venture Growth BDC
TPVG
$199M
| $821K | ﹤0.01% |
49,880
-26,721
| -35% | -$419K |
2017 Q1
10 quarters
|
|
3777
United Parks & Resorts
PRKS
$1.41B
| $820K | ﹤0.01% |
31,190
+5,250
| +20% | +$160K |
2015 Q4
15 quarters
|
|
|
EFC
3778
Ellington Financial
EFC
$1.51B
| $818K | ﹤0.01% |
45,310
-136,279
| -75% | -$2.42M |
2018 Q4
3 quarters
|
|
|
WPX
3779
CALL
DELISTED
WPX Energy, Inc.
WPX
| $815K | ﹤0.01% |
+77,000
| New | +$813K |
2019 Q3
0 quarters
|
|
3780
Stellus Capital Investment Corp
SCM
$211M
| $814K | ﹤0.01% |
59,752
+16,216
| +37% | +$223K |
2019 Q1
2 quarters
|
|
|
CBPO
3781
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $814K | ﹤0.01% |
7,114
-2,500
| -26% | -$249K |
2017 Q3
8 quarters
|
|
3782
PUT
Agios Pharmaceuticals
AGIO
$1.94B
| $810K | ﹤0.01% |
+25,000
| New | +$1.03M |
2019 Q3
0 quarters
|
|
|
NVTA
3783
DELISTED
Invitae Corporation
NVTA
| $810K | ﹤0.01% |
42,062
-42,908
| -50% | -$1.01M |
2017 Q4
7 quarters
|
|
|
TNAV
3784
DELISTED
Telenav Inc.
TNAV
| $809K | ﹤0.01% |
169,087
-66,812
| -28% | -$563K |
2017 Q4
7 quarters
|
|
3785
CALL
Automatic Data Processing
ADP
$105B
| $807K | ﹤0.01% |
5,000
-210,800
| -98% | -$34.8M |
2019 Q1
2 quarters
|
|
3786
Laureate Education
LAUR
$5.23B
| $804K | ﹤0.01% |
48,477
-68,153
| -58% | -$1.14M |
2017 Q3
8 quarters
|
|
|
MTL
3787
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $803K | ﹤0.01% |
429,330
+44,951
| +12% | +$86.3K |
2015 Q4
15 quarters
|
|
3788
Viper Energy
VNOM
$7.91B
| $802K | ﹤0.01% |
28,975
-42,793
| -60% | -$1.27M |
2016 Q2
13 quarters
|
|
3789
American Superconductor
AMSC
$1.43B
| $801K | ﹤0.01% |
102,146
+96,377
| +1,671% | +$819K |
2015 Q4
15 quarters
|
|
|
MRTX
3790
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $801K | ﹤0.01% |
10,281
+1,951
| +23% | +$183K |
2018 Q2
5 quarters
|
|
3791
Tejon Ranch
TRC
$446M
| $798K | ﹤0.01% |
47,027
+22,775
| +94% | +$397K |
2015 Q4
15 quarters
|
|
|
MTEM
3792
DELISTED
Molecular Templates, Inc.
MTEM
| $798K | ﹤0.01% |
8,076
+1,087
| +16% | +$101K |
2017 Q3
8 quarters
|
|
|
XLNX
3793
CALL
DELISTED
Xilinx Inc
XLNX
| $796K | ﹤0.01% |
8,300
-56,400
| -87% | -$6.17M |
2019 Q1
2 quarters
|
|
|
ESGR
3794
DELISTED
Enstar Group
ESGR
| $794K | ﹤0.01% |
4,179
+545
| +15% | +$97.8K |
2015 Q4
15 quarters
|
|
3795
Prothena Corp
PRTA
$438M
| $794K | ﹤0.01% |
101,283
-88,362
| -47% | -$785K |
2014 Q4
19 quarters
|
|
|
CARB
3796
DELISTED
Carbonite Inc
CARB
| $791K | ﹤0.01% |
51,098
+36,497
| +250% | +$650K |
2013 Q4
23 quarters
|
|
3797
Tronox
TROX
$610M
| $790K | ﹤0.01% |
95,187
+30,955
| +48% | +$298K |
2015 Q3
16 quarters
|
|
3798
Gyre Therapeutics
GYRE
$742M
| $789K | ﹤0.01% |
21,413
-8,152
| -28% | -$439K |
2018 Q2
5 quarters
|
|
3799
Metallus
MTUS
$805M
| $789K | ﹤0.01% |
125,398
+60,413
| +93% | +$396K |
2017 Q4
7 quarters
|
|
3800
Artesian Resources
ARTNA
$340M
| $788K | ﹤0.01% |
21,297
+2,833
| +15% | +$102K |
2013 Q2
25 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.